AdAlta Ltd on track to raise $3.15 million to fund early return to clinic for AD-214
AdAlta Ltd (ASX:1AD) is well on the way to an early return to the clinic with the novel therapeutic products from its i-body platform after raising $1.28...
Source: proactiveinvestors.com.au